Switzerland-based Roche Holdings AG has begun the reshuffling process of several of its executives following its $46.8 billion takeover of biotechnology company Genentech in March.

Intelligence, benchmarking, and certification for risk and compliance leaders, from the institution setting the standard since 1922.
Switzerland-based Roche Holdings AG has begun the reshuffling process of several of its executives following its $46.8 billion takeover of biotechnology company Genentech in March.
Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,... More by Jaclyn Jaeger
We'll send a verification code to %EMAIL%.